
|Articles|March 1, 2003
Good Food Additive
Oklahoma City - Results of preclinical and initial clinical studies indicate the investigational compound CX-452 has promising activity as a highly safe and very effective topical nonsteroidal anti-inflammatory and anti-aging agent, Bryan B. Fuller, Ph.D., said.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
AI Analysis Reveals Menopausal Hair Loss Linked to Systemic Health and Inflammation
3
Dual-Action Microneedle Patch Shows Promise for Psoriasis in Preclinical Study
4
Novel Botanical Moisturizer Demonstrates Superior Efficacy Over Metronidazole in Phase 2 Rosacea Trial
5














